Home › Clinical Tools › Framingham CHD

❤️ Framingham Hard CHD 10-Year Risk (ATP III Points)

UseWhen to use: primary-prevention adults 20–79 when teaching classic Framingham hard CHD risk (MI/CHD death).

Loading calculator…

StrataHigher points → higher 10-y hard CHD %; endpoint excludes stroke/HF unlike ASCVD.

LimitsWhen not to use: as the sole modern statin-eligibility tool when ASCV… · Pitfall: applying hard CHD % as if it included stroke. · Derived mainly from older Framingham cohorts — ancestry calibration l…

SourceNHLBI ATP III Framingham hard CHD point tables; note limitations vs ACC/AHA ASCVD

Runs locally in your browser (no PHI uploaded). For licensed clinicians — not a substitute for clinical judgement.
Stored on this device for revisit reminders

This-shift next steps

After scoring: open the scene pack, peer scores, and the matching pathway. Local reference — no HIS write.

Scene next step
📋ASCVD / China-PAROpen scene pack →
Related scores
Matching pathway
🧭htn_emergencyOpen pathway →
Score + version; reference only — not a substitute for care · no HIS write

Paste the link in Slack, Teams, X, or LinkedIn — the preview image comes from this page’s Open Graph card.

Methodology · worked example, guidelines & full notes
Clinical takeaway

Hard CHD ≠ ASCVD.

When to use

When to use: primary-prevention adults 20–79 when teaching classic Framingham hard CHD risk (MI/CHD death).

How it works

Sex-specific points for age, TC, HDL, SBP (±treatment), smoking from NHLBI ATP III tables → % hard CHD.

Key points

  • Hard CHD ≠ ASCVD.
  • Cite Framingham Heart Study / ATP III.
  • Next: ASCVD pooled cohort / China PCEs when used.

References

Worked calculation

The values below come from this tool's own example placeholders and are computed server-side with the formula shown on this page, so the arithmetic can be checked quickly. It demonstrates how to substitute values only — it is not clinical advice and not a real case.

SexMale
Age band50–54
Total cholesterol (mg/dL)200–239
HDL-C (mg/dL)50–59
SBP (mmHg)130–139
On antihypertensive treatmentNo
Current smokerNo
Diabetes mellitusNo

→10-y hard CHD6%

  • Point total：10
  • Band：Lower 10-y hard CHD risk band
  • Endpoint：Hard CHD = MI or CHD death (not stroke/HF)
SexMale
Age band20–34
Total cholesterol (mg/dL)< 160
HDL-C (mg/dL)≥ 60
SBP (mmHg)< 120
On antihypertensive treatmentNo
Current smokerNo
Diabetes mellitusNo

→10-y hard CHD<1%

  • Point total：-10
  • Band：Lower 10-y hard CHD risk band
  • Endpoint：Hard CHD = MI or CHD death (not stroke/HF)
Verification & sources · governance
FAQ

Frequently asked questions

Does Framingham Hard CHD 10-Year Risk (ATP III Points) upload patient data? Where is it calculated?
Calculation runs locally in the browser; inputs and results are not uploaded. For licensed clinicians only; interpret with history, investigations and local protocols — not a diagnosis or prescription.
How is Framingham Hard CHD 10-Year Risk (ATP III Points) calculated in practice? Can you show a worked example?
Inputs: Sex Male, Age band 50–54, Total cholesterol (mg/dL) 200–239, HDL-C (mg/dL) 50–59, SBP (mmHg) 130–139, On antihypertensive treatment No, Current smoker No, Diabetes mellitus No → Result: 10-y hard CHD 6 %（Point total: 10, Band: Lower 10-y hard CHD risk band, Endpoint: Hard CHD = MI or CHD death (not stroke/HF)） Inputs: Sex Male, Age band 20–34, Total cholesterol (mg/dL) < 160, HDL-C (mg/dL) ≥ 60, SBP (mmHg) < 120, On antihypertensive treatment No, Current smoker No, Diabetes mellitus No → Result: 10-y hard CHD <1 %（Point total: -10, Band: Lower 10-y hard CHD risk band, Endpoint: Hard CHD = MI or CHD death (not stroke/HF)）
Related tools

Other tools